The conjunctiva is a clear layer of tissue lining the eyelids and covering the white of the eye. Allergic conjunctivitis occurs when the conjunctiva becomes swollen or inflamed due to a reaction to pollen, dust mites, pet dander, mold, or other allergy-causing substances.
Conjunctivitis - allergic seasonal/perennial; Atopic keratoconjunctivitis; Pink eye - allergic
When your eyes are exposed to allergy-causing substances, a substance called histamine is released by your body. The blood vessels in the conjunctiva become swollen. The eyes can become red, itchy, and teary very quickly.
The pollens that cause symptoms vary from person to person and from area to area. Tiny, hard-to-see pollens that may cause allergic symptoms include grasses, ragweed and trees. These same pollens may also cause hay fever.
Your symptoms may be worse when there is more pollen in the air. Higher levels of pollen are more likely on hot, dry, windy days. On cool, damp, rainy days most pollen is washed to the ground.
Mold, animal dander, or dust mites may cause this problem also.
Allergies tend to run in families. It is hard to know exactly how many people have allergies. Many conditions are often lumped under the term "allergy" even when they might not truly be an allergy.
Symptoms may be seasonal and can include:
The best treatment is to avoid what causes your allergy symptoms as much as possible. Common triggers to avoid include dust, mold and pollen.
Some things you can do to ease symptoms are:
If home-care does not help, you may need to see a provider for treatments such as eye drops that contain antihistamines or eye drops that reduce swelling.
Mild eye steroid drops can be prescribed for more severe reactions. You may also use eye drops that prevent a type of white blood cell called mast cells from causing swelling. These drops are given along with antihistamines. These medicines work best if you take them before you come in contact with the allergen. Referral to an ophthalmologist before using steroid eye drops should be done since intraocular pressure measurements and a more thorough eye exam (using a slit lamp) is needed.
Andrea Leonardi practices in Padova, Italy. Leonardi is rated as an Elite expert by MediFind in the treatment of Allergic Conjunctivitis. She is also highly rated in 8 other conditions, according to our data. Her top areas of expertise are Allergic Conjunctivitis, Vernal Keratoconjunctivitis, Giant Papillary Conjunctivitis, and Conjunctivitis (Pink Eye).
Nobuyuki Ebihara practices in Urayasu, Japan. Ebihara is rated as an Elite expert by MediFind in the treatment of Allergic Conjunctivitis. He is also highly rated in 8 other conditions, according to our data. His top areas of expertise are Vernal Keratoconjunctivitis, Giant Papillary Conjunctivitis, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Corneal Transplant.
Akira Matsuda practices in Fukuoka, Japan. Matsuda is rated as an Elite expert by MediFind in the treatment of Allergic Conjunctivitis. They are also highly rated in 12 other conditions, according to our data. Their top areas of expertise are Allergic Conjunctivitis, Vernal Keratoconjunctivitis, Giant Papillary Conjunctivitis, Conjunctivitis (Pink Eye), and Corneal Transplant.
Symptoms often go away with treatment. However, they can persist if you continue to be exposed to the allergen.
Long-term swelling of the outer lining of the eyes may occur in those with chronic allergies or asthma. It is called vernal conjunctivitis. It is most common in young males, and most often occurs during the spring and summer.
There are no serious complications.
Contact your provider if:
Summary: To evaluate the efficacy of Combo (Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution) compared to its individual components and vehicle in a population of subjects with allergic conjunctivitis:
Summary: Primary objective: To assess the efficacy of a single dose of the anti- Bet v 1 monoclonal antibodies (mAb(s ) in the reduction of allergic nasal symptoms during an out-of-season birch allergen environmental exposure unit (EEU) challenge in participants receiving REGN5713-5714-5715 versus placebo (Part A)
Published Date: July 12, 2022
Published By: Stuart I. Henochowicz, MD, FACP, Clinical Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, Georgetown University Medical School, Washington, DC. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Cioffi GA, Liebmann JM. Diseases of the visual system. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 395.
Rubenstein JB, Patel P. Allergic conjunctivitis. In: Yanoff M, Duker JS, eds. Ophthalmology. 6th ed. Philadelphia, PA: Elsevier; 2023:chap 4.7.